Press Releases :: ContraFect Corporation (CFRX)

Press Releases

Investors & Media

ContraFect Receives Designation as a Small and Medium Enterprise by the European Medicines Agency

August 4, 2016

ContraFect Corporation Prices $35 Million Public Offering of Common Stock and Warrants

July 22, 2016

ContraFect Corporation Names Steven C. Gilman, PhD Chief Executive Officer

July 21, 2016

ContraFect Corporation Announces Proposed Public Offering of Common Stock and Warrants

July 21, 2016

ContraFect Presents New CF-301 Data at ASM Microbe 2016

June 21, 2016

ContraFect Announces Presentation of Data at ASM Microbe 2016

June 8, 2016

ContraFect to Present at Jefferies 2016 Healthcare Conference

June 1, 2016

ContraFect Announces First Quarter 2016 Results

May 10, 2016

ContraFect Corporation to Announce First Quarter 2016 Results on May 10, 2016

May 3, 2016

ContraFect to Present CF-301 Phase 1 Trial Data at the 26th ECCMID Conference

March 29, 2016